Browsing by Author Arellano-Olivera, I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
Adenoviral delivery of dominant-negative transforming growth factor ? type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in ratsMarquez-Aguirre, A.; Sandoval-Rodriguez, A.; Gonzalez-Cuevas, J.; Bueno-Topete, M.; Navarro-Partida, J.; Arellano-Olivera, I.; Lucano-Landeros, S.; Armendariz-Borunda, J.--
Adenoviral delivery of dominant-negative transforming growth factor β type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in ratsMarquez-Aguirre, A.; Sandoval-Rodriguez, A.; Gonzalez-Cuevas, J.; Bueno-Topete, M.; Navarro-Partida, J.; Arellano-Olivera, I.; Lucano-Landeros, S.; Armendariz-Borunda, J.--
Fibrogenic polymorphisms (TGF-β, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatmentArmendariz-Borunda, J.; Rincon, A.R.; Munoz-Valle, J.F.; Bueno-Topete, M.; Oregon-Romero, E.; Islas-Carbajal, M.C.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Bautista, A.; Garcia-Rocha, S.; Godoy, J.; Mercado, M.V.-D.; Troyo-SanRoman, R.; Arellano-Olivera, I.; Lucano, S.; Alvarez-Rodriguez, A.; Salazar, A.--
Nuclear genome size and cytotype analysis in Agave cupreata Trel. & Berger (Agavaceae)Armendariz-Borunda, J.; Rincon, A.R.; Munoz-Valle, J.F.; Bueno-Topete, M.; Oregon-Romero, E.; Islas-Carbajal, M.C.; Medina-Preciado, D.; Gonzalez-García, I.; Bautista, A.; García-Rocha, S.; Godoy, J.; Mercado, M.V.-D.; Troyo-SanRoman, R.; Arellano-Olivera, I.; Lucano, S.; Alvarez-Rodriguez, A.; Salazar, A.--
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CFlores-Contreras, L.; Sandoval-Rodriguez, A.S.; Mena-Enriquez, M.G.; Lucano-Landeros, S.; Arellano-Olivera, I.; Alvarez-Alvarez, A.; Sanchez-Parada, M.G.; Armendariz-Borunda, J.--
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CFlores-Contreras, L.; Sandoval-Rodriguez, A.S.; Mena-Enriquez, M.G.; Lucano-Landeros, S.; Arellano-Olivera, I.; Alvarez-Alvarez, A.; Sanchez-Parada, M.G.; Armendariz-Borunda, J.--